Uniqure (QURE.US) Financial Statements - Balance Sheet/Income Statement/Cash Flow - Longbridge

Quote List Quote List

Event Tracking

Dec4

uniQure N.V. Plans to Request Follow-up Meeting with FDA in Q1 2026 for Huntington's Gene Therapy AMT-130

12:16

Nov20

uniQure's stock falls 8.7% in midday trading, analysts lower price targets

19:07

Nov14

HC Wainwright 下调 uniQure 的每股收益预期至 3.85 美元

17:26

Texas Teachers Retirement System Acquired Uniqure N.V. Stocks in Q2

10:48

Nov12

H.C. Wainwright Maintains Buy Rating for uniQure with a Price Target of $70

14:23

uniQURE N.V. Under Investigation for Securities Law Violations

01:07

Schedules & Filings

Schedules

Filings

Nov10

Earning Release(EST)

FY2025 Q3 Earning Release (USD) Revenue 3.701 M, Net Income -80.53 M, EPS -1.3761

Jul29

Earning Release(EST)

FY2025 Q2 Earning Release (USD) Revenue 5.262 M, Net Income -37.72 M, EPS -0.6882

May9

Earning Release(EST)

FY2025 Q1 Earning Release (USD) Revenue 1.567 M, Net Income -43.64 M, EPS -0.8216

View More

Stock List

Top Gainers

Top Decliners

China Concepts

Symbol

Price

%Chg

Change

View More